| Dr Edward George Buchsbaum, MD | |
|
20911 Earl Street, Suite 301, Torrance, CA 90503 | |
| (310) 371-1388 | |
| (310) 371-3439 |
| Full Name | Dr Edward George Buchsbaum |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 48 Years |
| Location | 20911 Earl Street, Torrance, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376648170 | NPI | - | NPPES |
| 00G364320 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | G36432 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Torrance Memorial Medical Center | Torrance, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Bay Allergy And Asthma Assoc | 3173565694 | 2 |
News Archive
Canada's first human gene therapy trial for eyes - the replacement of a faulty gene with a healthy one - is now underway at the Royal Alexandra Hospital to preserve and potentially restore vision for people with a genetic disorder that leaves them blind by middle age.
Regado Biosciences, Inc., a private biopharmaceutical company leading the development of antithrombotic aptamers with matched active control agents, announced today that it has received funding from the United States government under the Qualifying Therapeutic Discovery Project (QTDP) grants program to advance the development of the company's three programs, REG1, REG2 and REG3.
An estimated 20 million Americans have chronic heartburn. About 2 million of these people have Barrett's esophagus, a precancerous condition that affects the tube that carries food from the mouth to the stomach.
Sevocity, a division of Conceptual MindWorks, Inc., today announced free state immunization registry interfaces/links for all Sevocity EHR customers.
› Verified 1 days ago
| Entity Name | South Bay Allergy & Asthma Assoc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528163334 PECOS PAC ID: 3173565694 Enrollment ID: O20050525000453 |
News Archive
Canada's first human gene therapy trial for eyes - the replacement of a faulty gene with a healthy one - is now underway at the Royal Alexandra Hospital to preserve and potentially restore vision for people with a genetic disorder that leaves them blind by middle age.
Regado Biosciences, Inc., a private biopharmaceutical company leading the development of antithrombotic aptamers with matched active control agents, announced today that it has received funding from the United States government under the Qualifying Therapeutic Discovery Project (QTDP) grants program to advance the development of the company's three programs, REG1, REG2 and REG3.
An estimated 20 million Americans have chronic heartburn. About 2 million of these people have Barrett's esophagus, a precancerous condition that affects the tube that carries food from the mouth to the stomach.
Sevocity, a division of Conceptual MindWorks, Inc., today announced free state immunization registry interfaces/links for all Sevocity EHR customers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Edward George Buchsbaum, MD 20911 Earl Street, Suite 301, Torrance, CA 90503 Ph: (310) 371-1388 | Dr Edward George Buchsbaum, MD 20911 Earl Street, Suite 301, Torrance, CA 90503 Ph: (310) 371-1388 |
News Archive
Canada's first human gene therapy trial for eyes - the replacement of a faulty gene with a healthy one - is now underway at the Royal Alexandra Hospital to preserve and potentially restore vision for people with a genetic disorder that leaves them blind by middle age.
Regado Biosciences, Inc., a private biopharmaceutical company leading the development of antithrombotic aptamers with matched active control agents, announced today that it has received funding from the United States government under the Qualifying Therapeutic Discovery Project (QTDP) grants program to advance the development of the company's three programs, REG1, REG2 and REG3.
An estimated 20 million Americans have chronic heartburn. About 2 million of these people have Barrett's esophagus, a precancerous condition that affects the tube that carries food from the mouth to the stomach.
Sevocity, a division of Conceptual MindWorks, Inc., today announced free state immunization registry interfaces/links for all Sevocity EHR customers.
› Verified 1 days ago
Dr. Heather Suzanne Volpp, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 20911 Earl St Ste 301, Torrance, CA 90503 Phone: 310-371-1388 Fax: 310-371-3439 | |
Ellyn Ashida, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 4201 Torrance Blvd, 730, Torrance, CA 90503 Phone: 310-944-9098 | |
Dr. Allan David Singer, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3440 Lomita Blvd, Ste 228, Torrance, CA 90505 Phone: 310-326-3371 Fax: 310-326-2294 | |
Julia Shin Lee, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 20911 Earl St Ste 301, Torrance, CA 90503 Phone: 310-371-1388 Fax: 310-371-3439 | |
Dr. Dean Ting-yuan Chiang, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 3440 Lomita Blvd, Suite 228, Torrance, CA 90505 Phone: 310-326-3371 Fax: 310-326-2294 | |
Joyce Jeong-mi Schoettler, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 20911 Earl St Ste 301, Torrance, CA 90503 Phone: 310-371-1388 Fax: 310-371-3439 |